Last reviewed · How we verify
NCT05093764
Quantification of Debris Captured Using TCEP During VIV TAVR With BVF
NA trial testing VIV TAVR with BVF using TCEP in Aortic Valve Disease in 20 participants. Currently enrolling.
31 December 2024
Quick facts
| Lead sponsor | Saint Luke's Health System |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 2 March 2022 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- VIV TAVR with BVF using TCEP
Conditions studied
- Aortic Valve Disease — all drugs for Aortic Valve Disease →
Sponsor
Saint Luke's Health System — full company profile →
Who can join
18 and older, any sex, with Aortic Valve Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to quantify the amount of debris captured by the SENTINEL transcatheter cerebral embolic protection (TCEP) device in patients undergoing valve in valve transcatheter aortic valve replacement (VIV TAVR) with bioprosthetic valvular fracture (BVF)
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05093764
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aortic Valve Disease
Currently open trials in the same condition.
- NCT07008911 — CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation · NA · recruiting
- NCT07267117 — Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease · recruiting
- NCT07021612 — A Clinical and Imaging Registry of Transcatheter Aortic Valve Implantation Using JenaValve System/ J-Valve System for Pa · recruiting
- NCT06896227 — TAVR: The Impact of Prothesis Positioning on Valvular and Coronary Hemodynamics · NA · recruiting
- NCT06189976 — Rapid Atrial Pacing After TAVI to Predict Pacemaker Implantation · NA · recruiting
Other Saint Luke's Health System trials
Trials by the same sponsor.
- NCT06969365 — Weighted Blankets for IUD Insertion · Phase 1 · enrolling by invitation
- NCT05900362 — Feasibility and Success Trial of Remote Patient Monitoring in Heart Failure · NA · not yet recruiting
- NCT05089864 — STAR and Deferred Stenting Study · NA · completed
- NCT03664466 — Astaxanthin Effects on Osteoarthritis Associated Pain and Inflammatory Indicators · NA · withdrawn
- NCT05229926 — Implementation of CareCube Negative Pressure Isolation Units · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05093764 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Saint Luke's Health System
- Last refreshed: 14 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05093764.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing